Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03193593 · ClinicalTrials.gov registry record · Phase 2
Study to Evaluate EB-001 in Reducing Musculoskeletal Pain
A Phase 2 study, sponsored by Bonti.
- Completed
- Registry status
- Phase 2
- Development phase
- 66
- Enrollment target
NCT03193593: Completed Phase 2 study, sponsored by Bonti.
NCT03193593 is a Phase 2 study that has completed, run by Bonti. The registered enrollment target is 66 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (50% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03193593, a Phase 2 study, has completed, sponsored by Bonti.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 66 participants
- Enrollment target
Study Summary
To determine the safety and efficacy of single intra-operative treatment of EB-001 IM injections into the Pectoralis Major (PM) in subjects undergoing breast augmentation with subpectoral implants
Primary Outcome
Subject's assessment of pain using the Numeric Pain Rating Scale (1= No Pain, 10= Maximum Pain) for the first 96 hours following injection, expressed as AUC over the 16h to 96h period following dosing.
Interventions
- DRUG Placebo
- DRUG EB-001
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2017-08-29 |
| Est. Completion | 2018-08-07 |
| Phase | Phase 2 |
What the finished NCT03193593 record still lists
NCT03193593 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 66 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (50% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03193593 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03193593 about?
NCT03193593 is a clinical study titled "Study to Evaluate EB-001 in Reducing Musculoskeletal Pain". To determine the safety and efficacy of single intra-operative treatment of EB-001 IM injections into the Pectoralis Major (PM) in subjects undergoing breast augmentation with subpectoral implants
What is the current status of trial NCT03193593?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 66 participants. The study started on 2017-08-29. Estimated completion is 2018-08-07.
What interventions are being tested in trial NCT03193593?
The interventions under investigation include: Placebo (DRUG), EB-001 (DRUG).
Who is sponsoring clinical trial NCT03193593?
This trial is sponsored by Bonti, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03193593's enrollment target sits among peer trials
66 975th of 2000 higher than 1,014 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02584244 · 66 participants · Phase 1
Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers
- NCT03067051 · 66 participants · Phase 1
Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System
- NCT03754725 · 66 participants · Phase 1
Ferritin and Iron Burden in SAH sIRB
- NCT03875378 · 66 participants · Phase 2
Transdermal Estrogen in Women With Anorexia Nervosa
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI